Arrowhead Pharmaceuticals (ARWR) EBITDA Margin (2010 - 2026)
Arrowhead Pharmaceuticals' EBITDA Margin was -217.18% in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 356.62 percentage points from -573.80% a year earlier but down 34.24 percentage points from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) EBITDA Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Arrowhead Pharmaceuticals' EBITDA Margin was -29.97% through Jun 30, 2026, down 15.06 percentage points year-over-year; for FY2025 (ended Sep 30, 2025), it was 14.74%, up 16418.15 percentage points from FY2024.
- EBITDA Margin shows a five-year change of +113.86 percentage points (FY2020 to FY2025).
- In earlier fiscal years, EBITDA Margin was -16403.41% in FY2024 (-16323.44 pp), -79.97% in FY2023 (-10.86 pp), -69.11% in FY2022 (+32.69 pp) and -101.79% in FY2021 (-2.68 pp).
- Quarterly EBITDA Margin has moved between -6247.08% (fiscal Q1 2025) and 71.36% (fiscal Q2 2025) over five years.
- Compared with a year earlier, EBITDA Margin was higher in two of the last four quarters, with an average year-over-year change of +961.35 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was fiscal Q1 2026 (a gain of 6264.96 percentage points); the worst was fiscal Q1 2024 (a drop of 3662.14 percentage points).
- Per Business Quant data, ARWR's EBITDA Margin in the three fiscal quarters before Q3 2026 was -182.94% (Q2 2026), 17.88% (Q1 2026) and 19.69% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | -217.18% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -217.18% |
| Mar 31, 2026 | -182.94% |
| Dec 31, 2025 | 17.88% |
| Sep 30, 2025 | 19.69% |
| Jun 30, 2025 | -573.80% |
| Mar 31, 2025 | 71.36% |
| Dec 31, 2024 | -6,247.08% |
| Dec 31, 2023 | -3,725.20% |
| Sep 30, 2023 | -649.01% |
| Jun 30, 2023 | -628.29% |
| Mar 31, 2023 | 34.75% |
| Dec 31, 2022 | -63.07% |
| Sep 30, 2022 | -257.07% |
| Jun 30, 2022 | -216.94% |
| Mar 31, 2022 | 29.08% |
| Dec 31, 2021 | -221.39% |
| Sep 30, 2021 | -162.94% |
| Jun 30, 2021 | -65.09% |
| Mar 31, 2021 | -80.20% |
| Dec 31, 2020 | -104.24% |
Arrowhead Pharmaceuticals EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();